Czechia – Medicinal products for the blood and blood-forming organs – Low molecular weight heparins (LMWH)
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The subject of the public contract is the supply of medicinal products from the LMWH group in approved indications according to the SPC valid on the date of submission of the offer (with the exception of the indication Prolonged treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of its recurrence in patients with active cancer.